Brief: Revive Therapeutics Announces Exclusive License Agreement With Wisconsin Alumni Research Foundation For Cannabinoid Delivery Technology
30/04/2018 12:06
April 30 (Reuters) - Revive Therapeutics Ltd RVV.V :
* REVIVE THERAPEUTICS ANNOUNCES EXCLUSIVE LICENSE AGREEMENT
WITH
WISCONSIN ALUMNI RESEARCH FOUNDATION FOR CANNABINOID DELIVERY
TECHNOLOGY
Source text for Eikon: ID:nGNXbf6B3
Further company coverage: RVV.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revive Therapeutics
See all newsBrief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Provides Update Of Key Nerve Agent Countermeasure Study
Brief: Revive Therapeutics Announces Closing Of Second Tranche Of Private Placement
Brief: Revive Therapeutics Nears Completion Of Key Nerve Agent Countermeasure Study With Canadian Department Of National Defence
Brief: Revive Therapeutics Provides Update On Research Study Evaluating Bucillamine For Nerve Agent Exposure